Timothy Eugene Sullivan's Net Worth

$10.6 Million

Estimate Recalculated Nov 4, 2024 02:37AM EST

Who is Timothy Eugene Sullivan

Timothy Eugene Sullivan has an estimated net worth of $10.6 Million. This is based on reported shares across multiple companies, which include Apellis Pharmaceuticals, Inc., and G1 Therapeutics, Inc..

SEC CIK

Timothy Eugene Sullivan's CIK is 0001707000

Past Insider Trading and Trends

2023 was Timothy Eugene Sullivan's most active year for acquiring shares with 7 total transactions. Timothy Eugene Sullivan's most active month to acquire stocks was the month of December. 2023 was Timothy Eugene Sullivan's most active year for disposing of shares, totalling 18 transactions. Timothy Eugene Sullivan's most active month to dispose stocks was the month of December. 2024 saw Timothy Eugene Sullivan paying a total of $2,389,837.90 for 68,281 shares, this is the most they've acquired in one year. In 2023 Timothy Eugene Sullivan cashed out on 242,543 shares for a total of $7,841,151.27, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Apellis Pharmaceuticals, Inc.

Chief Financial Officer
Updated Apr 19, 2024
149.57KApr 18
ScheduledApr 01
ScheduledMar 01
Feb 12
Jan 29
Jan 22
Jan 16
ScheduledNov 30
Jul 03
Jun 05
133.95KMay 03
133.95KApr 19
Feb 21
Feb 10
Jan 27
Jan 20
Apr 25 - Jan 12
Feb 10
Jan 28
148.60KJan 21
Jun 08
Feb 10
57.62KJan 28
93.51KFeb 10
Aug 29
95.00KFeb 08
25.00KFeb 16
Showing 28 results

G1 Therapeutics, Inc.

Investor
Updated May 19, 2017
Showing 1 results